Month: June 2017

Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system

Jared Beaumont, M.P.H.1, Theresa Cassidy, M.P.H.1, Taryn Dailey Govoni, M.P.H.1 Presented at International Conference on Opioids 2017 See our poster for “Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system” here Abstract Post-market surveillance data indicate low abuse levels of tapentadol products, but research regarding the route of administration… Read more »

Inflexxion to present at the International Conference on Opioids

The International Conference on Opioids is taking place June 11-13 in Boston, MA.  This years conference continues to focus on exploring the use of opioids for pain management. As part of the conference, Inflexxion will be presenting an educational session on Monday, June 12 at 2:45pm titled, Assessment, Treatment, and Outcome of Pain Patients at Risk for… Read more »

Webinar for California Providers: How a standardized electronic assessment can help you comply with ASAM criteria for DMC-ODS

The Drug Medi-Cal Organized Delivery System (DMC-ODS) requires that providers use the ASAM criteria in their assessment and placement decisions.  The ASI-MV (Addiction Severity Index – Multimedia Version) online, client self-administered assessment can assist you in gathering the data needed to make your ASAM placement decisions.  It is an evidenced-based tool that is valid, reliable and… Read more »

Customer Enhancement Training Series on June 21

Join us for this months enhanced training series – ASI-MV & BHI-MV – Bridging data into treatment planning.  Whether you’re looking to learn more about reporting, or you have a new staff member, this training provides a complete overview of the ASI-MV & BHI-MV tools. As part of this training, you will: Gain an understanding of… Read more »